Multicenter randomized phase II study of cisplatin and fluorouracil plus docetaxel (DCF) compared with cisplatin and fluorouracil plus Adriamycin (ACF) as preoperative chemotherapy for resectable esophageal squamous cell carcinoma (OGSG1003)Makoto Yamasaki, Yuichiro� Doki, Takushi Yasuda et al.|Annals of Oncology|2016Cited by 128
Multicenter prospective trial of total gastrectomy versus proximal gastrectomy for upper third cT1 gastric cancerMakoto Yamasaki, Yuichiro� Doki, Yusuke Akamaru et al.|Gastric Cancer|2020Cited by 77
Feasibility of Preoperative Chemotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil versus Adriamycin, Cisplatin, and 5-Fluorouracil for Resectable Advanced Esophageal CancerOsamu Shiraishi, Takushi Yasuda, Makoto Yamasaki et al.|Oncology|2016Cited by 44
Skeletal Muscle Loss during Neoadjuvant Chemotherapy Is an Independent Risk Factor for Postoperative Infectious Complications in Patients with Advanced Esophageal CancerMasaaki Motoori, Masahiko Yano, Kazumasa Fujitani et al.|Oncology|2018Cited by 43
Multicenter randomised trial of two versus three courses of preoperative cisplatin and fluorouracil plus docetaxel for locally advanced oesophageal squamous cell carcinomaTomoki Makino, Takushi Yasuda, Makoto Yamasaki et al.|British Journal of Cancer|2022Cited by 40